GO:0070944 neutrophil-mediated killing of bacterium: Immune Defense Mechanism, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0070944 describes the directed killing of a bacterium by a neutrophil, a core effector process of innate immunity.
• Neutrophils kill bacteria through phagocytosis, degranulation, reactive oxygen species, and neutrophil extracellular traps (NETs).
• Pathogens such as Staphylococcus aureus, Pseudomonas aeruginosa, and Providencia species evade neutrophil killing via leukocidins, nuclease Nuc, capsule modification, and NET subversion.
• Impaired neutrophil-mediated bacterial killing is observed in COVID-19 patients and correlates with disease severity.
• Quantitative models integrating phagocytosis and digestion kinetics help predict neutrophil bactericidal activity across in vitro and in vivo studies.
• CRISPR-based knockout, knock-in, and overexpression models are essential to dissect genes controlling neutrophil bactericidal function.
Description
Neutrophils are the most abundant circulating leukocytes and serve as first responders against bacterial infection. The Gene Ontology term GO:0070944, neutrophil-mediated killing of bacterium, captures the directed process by which a neutrophil kills a bacterium. This process is central to innate immune defense and involves recognition, phagocytosis, degranulation, oxidative burst, and in some cases neutrophil extracellular trap (NET) formation. Understanding this term is critical because many bacterial pathogens have evolved mechanisms to evade neutrophil killing, leading to persistent infections and therapeutic challenges. For researchers, GO:0070944 provides a standardized framework to annotate genes, proteins, and pathways involved in neutrophil bactericidal activity. Experimental studies have shown that neutrophil-mediated killing can be impaired in disease states such as COVID-19, and that bispecific antibodies can enhance killing of Pseudomonas aeruginosa in patients with bronchiectasis. Quantitative systems pharmacology models further support the integration of phagocytosis and digestion data to predict bacterial killing outcomes.
neutrophil-mediated killing of bacterium At A Glance
| GO ID | GO:0070944 |
|---|---|
| GO term | neutrophil-mediated killing of bacterium |
| Ontology | biological_process |
| Synonym | neutrophil mediated killing of bacterium |
| Major function | Directed killing of bacteria by neutrophils through phagocytosis, degranulation, oxidative burst, and NET formation |
| Related cell type | Neutrophil (polymorphonuclear leukocyte) |
| Pathogen examples | Staphylococcus aureus, Pseudomonas aeruginosa, Providencia rettgeri, Providencia stuartii, uropathogenic Escherichia coli |
| Evasion mechanisms | Leukocidins, nuclease Nuc, capsule O-acetylation, NET subversion |
| Disease relevance | Impaired killing in COVID-19; chronic infections in bronchiectasis and biofilm-associated infections |
What Is GO:0070944?
GO:0070944 is defined as the directed killing of a bacterium by a neutrophil. It encompasses all molecular and cellular events by which a neutrophil recognizes, engulfs, and destroys a bacterial cell, including phagocytosis, granule release, reactive oxygen species production, and extracellular trap formation.
Why Is neutrophil-mediated killing of bacterium Important in Cell Biology?
Neutrophil-mediated killing of bacterium is a cornerstone of innate immunity and a major determinant of infection outcome. Dysregulation or evasion of this process contributes to chronic and severe bacterial infections, including those caused by Staphylococcus aureus, Pseudomonas aeruginosa, and Providencia species. Understanding the molecular players and evasion strategies is essential for developing novel anti-infective therapies, such as bispecific antibodies that enhance neutrophil killing. Moreover, quantitative models of phagocytosis and digestion provide a framework to predict bactericidal efficacy and optimize treatment regimens.
• First-line defense against bacterial pathogens
• Critical for clearance of Staphylococcus aureus and Pseudomonas aeruginosa
• Target of bacterial immune evasion mechanisms such as leukocidins and NET degradation
• Impaired in COVID-19 patients, linking viral infection to secondary bacterial risk
• Enhanced by bispecific antibodies targeting Psl and PcrV in bronchiectasis
• Modulated by capsule modifications in uropathogenic E. coli
• Quantitative models can predict bacterial killing across in vitro and in vivo settings
• Provides a standardized GO annotation for gene function studies
• Relevant to biofilm-associated infections where neutrophils fail to clear bacteria
• Potential target for host-directed therapies to overcome antibiotic resistance
What Happens During neutrophil-mediated killing of bacterium?
Recognition and Chemotaxis
In simple terms: Neutrophils sense chemical signals from bacteria and move toward them.
Neutrophils are recruited to sites of infection by chemotactic gradients and recognize bacteria through pattern recognition receptors and opsonins. This initial step is essential for directed killing and involves complement and antibody-mediated recognition.
Phagocytosis
In simple terms: The neutrophil engulfs the bacterium into a vesicle called a phagosome.
Phagocytosis of bacteria by neutrophils involves receptor-mediated uptake, actin polymerization, and formation of a phagosome. This process is a major mechanism of neutrophil-mediated killing and has been quantitatively modeled to assess digestion kinetics.
Degranulation and Oxidative Burst
In simple terms: The neutrophil releases toxic granules and reactive oxygen species to destroy the bacterium.
Following phagosome formation, neutrophils undergo degranulation, releasing antimicrobial peptides and proteases, and activate the NADPH oxidase complex to produce reactive oxygen species. These mechanisms are critical for killing Staphylococcus aureus and other pathogens.
Neutrophil Extracellular Trap (NET) Formation
In simple terms: Neutrophils can release web-like structures that trap and kill bacteria outside the cell.
NETs are composed of DNA and antimicrobial proteins and can capture and kill bacteria. However, pathogens such as Providencia rettgeri and Providencia stuartii can evade killing by subverting NETs.
Bacterial Evasion and Subversion
In simple terms: Bacteria have evolved ways to escape or neutralize neutrophil killing.
Staphylococcus aureus uses leukocidins and nuclease Nuc to prevent killing in biofilms. Capsule O-acetylation in uropathogenic E. coli K1 enhances resistance to neutrophil killing. These evasion strategies highlight the dynamic arms race between host and pathogen.
Key Genes Involved in GO:0070944 neutrophil-mediated killing of bacterium
The following genes and proteins are central to neutrophil-mediated killing of bacterium, based on experimental evidence from the cited literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| Psl | Exopolysaccharide involved in Pseudomonas aeruginosa biofilm and immune evasion | Target of bispecific antibody enhancing neutrophil killing |
| PcrV | Type III secretion system component of Pseudomonas aeruginosa | Target of bispecific antibody enhancing neutrophil killing |
| Nuc | Staphylococcal nuclease that degrades NETs | Prevents neutrophil-mediated killing of S. aureus biofilms |
| Leukocidins | Pore-forming toxins that lyse neutrophils | Key evasion mechanism of S. aureus |
| NeuO | O-acetyltransferase modifying E. coli K1 capsule | Enhances resistance to phage and neutrophil killing |
| NET components | DNA and antimicrobial proteins forming extracellular traps | Subverted by Providencia species |
| NADPH oxidase | Produces reactive oxygen species | Essential for oxidative killing |
| Myeloperoxidase | Generates hypochlorous acid | Antimicrobial granule enzyme |
| Elastase | Serine protease in azurophilic granules | Degrades bacterial virulence factors |
| Cathepsin G | Serine protease with antimicrobial activity | Granule component |
| Defensins | Antimicrobial peptides | Direct bacterial killing |
| Complement receptors | Mediate opsonin-dependent phagocytosis | Recognition step |
| Fc receptors | Bind antibody-opsonized bacteria | Enhance phagocytosis |
| TLRs | Pattern recognition receptors | Detect bacterial ligands |
| IL-8 | Chemokine recruiting neutrophils | Amplifies neutrophil recruitment |
| TNF-alpha | Proinflammatory cytokine | Activates neutrophil bactericidal function |
| GM-CSF | Granulocyte-macrophage colony-stimulating factor | Priming of neutrophils |
| IFN-gamma | Cytokine enhancing neutrophil killing | Immune activation |
How Is neutrophil-mediated killing of bacterium Regulated?
Neutrophil-mediated killing of bacterium is regulated by cytokines such as GM-CSF, TNF-alpha, and IFN-gamma, which prime neutrophils for enhanced bactericidal activity. Bacterial factors, including leukocidins and nuclease Nuc, can suppress this process. Additionally, capsule modifications in E. coli K1 modulate resistance to killing. Quantitative models suggest that phagocytosis and digestion rates are key parameters that can be modulated by host and pathogen factors.
neutrophil-mediated killing of bacterium and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| Psl/PcrV | Bronchiectasis with Pseudomonas aeruginosa | Bispecific antibody treatment in patient-derived neutrophils |
| Nuc | Staphylococcus aureus biofilm infection | Nuc knockout S. aureus in biofilm model |
| NeuO | Uropathogenic E. coli K1 infection | neuO knockout E. coli in neutrophil killing assay |
| NET components | Providencia rettgeri/stuartii infection | NET inhibition or degradation assays |
| NADPH oxidase | Chronic granulomatous disease | Neutrophil oxidative burst assays |
COVID-19 and Impaired Neutrophil Killing
Neutrophils from COVID-19 patients show decreased bacterial killing capacity, which may contribute to secondary bacterial infections and worse outcomes.
Bronchiectasis and Pseudomonas aeruginosa Infection
In patients with bronchiectasis, bispecific monoclonal antibodies targeting Psl and PcrV enhance neutrophil-mediated killing of Pseudomonas aeruginosa, suggesting a therapeutic strategy for chronic infection.
Staphylococcus aureus Biofilm Infections
Staphylococcus aureus biofilms resist neutrophil killing through leukocidins and nuclease Nuc, leading to persistent infections.
Providencia Infections and NET Evasion
Clinical isolates of Providencia rettgeri and Providencia stuartii evade neutrophil-mediated killing by subverting neutrophil extracellular traps, highlighting a mechanism of immune escape.
From neutrophil-mediated killing of bacterium-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does gene X regulate neutrophil killing? | CRISPR knockout in neutrophil-like cell lines (e.g., HL-60) or primary neutrophils |
| Does a point mutation in gene X affect bacterial killing? | CRISPR point mutation knock-in in neutrophil progenitors |
| Does overexpression of gene X enhance killing? | CRISPR overexpression or lentiviral transduction in neutrophils |
| Does tag affect localization of protein X? | CRISPR tagged knock-in with fluorescent tag |
| Does bacterial gene Y mediate evasion? | CRISPR knockout in bacterial strains followed by neutrophil killing assay |
| Does antibody targeting bacterial antigen enhance killing? | Bispecific antibody in ex vivo neutrophil killing assay |
How to Study the neutrophil-mediated killing of bacterium Process
| Method | What It Measures | Typical Application |
|---|---|---|
| CFU killing assay | Bacterial survival after neutrophil incubation | Testing neutrophil bactericidal activity |
| Phagocytosis assay | Uptake of fluorescent bacteria | Quantifying phagocytic index |
| Oxidative burst assay | ROS production | Assessing NADPH oxidase activity |
| NET quantification | Extracellular DNA release | Studying NET formation and evasion |
| Quantitative systems pharmacology | Phagocytosis and digestion rates | Predicting in vivo killing |
| CRISPR knockout screen | Gene requirement for killing | Identifying host factors |
| Bispecific antibody assay | Enhanced killing | Therapeutic development |
| Biofilm killing assay | Bacterial survival in biofilms | Testing anti-biofilm strategies |
In Vitro Neutrophil Killing Assays
Neutrophils isolated from blood or differentiated from cell lines are incubated with bacteria, and surviving CFU are quantified. This method directly measures neutrophil-mediated killing and is used to test antibodies or gene knockouts.
Phagocytosis and Digestion Modeling
Quantitative models integrate phagocytosis and digestion data to predict bacterial killing across in vitro and in vivo studies, providing a systems-level understanding.
NET Visualization and Quantification
Neutrophil extracellular traps are visualized by fluorescence microscopy and quantified by DNA release assays. This is critical for studying pathogens that subvert NETs.
CRISPR Screening in Neutrophil Models
Genome-wide CRISPR screens in neutrophil-like cell lines can identify host genes required for bacterial killing, enabling discovery of novel therapeutic targets.
How CRISPR Can Be Used to Study GO:0070944 neutrophil-mediated killing of bacterium
Knockout
CRISPR knockout of candidate genes in neutrophil-like cell lines or primary neutrophils can determine whether a gene is required for bacterial killing. For example, knocking out NADPH oxidase components would impair oxidative burst and reduce killing.
Point Mutation
CRISPR point mutation knock-in can model human polymorphisms or disease-associated variants in genes such as NCF1 or CYBB to study their impact on neutrophil killing.
Knock-in
Tagged knock-in of genes like MPO or ELANE with fluorescent reporters allows real-time tracking of granule release during bacterial killing.
Overexpression
CRISPR overexpression of antimicrobial peptides or cytokines such as IFN-gamma can enhance neutrophil bactericidal activity and be tested in killing assays.
How EDITGENE Supports neutrophil-mediated killing of bacterium Research
Researchers studying neutrophil-mediated killing of bacterium-related genes often need to determine whether a candidate gene is causally involved in bacterial clearance or immune evasion. EDITGENE provides comprehensive CRISPR services to accelerate this discovery.
Contact EDITGENE today to design your custom CRISPR model for neutrophil-mediated killing of bacterium research.
Frequently Asked Questions About neutrophil-mediated killing of bacterium
What is GO:0070944?
GO:0070944 is the Gene Ontology term for neutrophil-mediated killing of bacterium, defined as the directed killing of a bacterium by a neutrophil.
What genes are involved in neutrophil-mediated killing of bacterium?
Key genes include Psl, PcrV, Nuc, NeuO, NADPH oxidase components, myeloperoxidase, and various granule proteases.
How do neutrophils kill bacteria?
Neutrophils kill bacteria through phagocytosis, degranulation, oxidative burst, and neutrophil extracellular trap formation.
How do bacteria evade neutrophil killing?
Bacteria evade killing via leukocidins, nuclease Nuc, capsule O-acetylation, and NET subversion.
What diseases are associated with impaired neutrophil-mediated killing?
COVID-19, bronchiectasis, chronic granulomatous disease, and biofilm-associated infections.
What methods are used to study neutrophil-mediated killing?
CFU killing assays, phagocytosis assays, oxidative burst assays, NET quantification, and quantitative modeling.
Can CRISPR be used to study neutrophil-mediated killing?
Yes, CRISPR knockout, knock-in, point mutation, and overexpression models are powerful tools to dissect gene function in neutrophil bactericidal activity.
What is the role of NETs in neutrophil-mediated killing?
NETs trap and kill bacteria, but some pathogens like Providencia species can subvert them.
How is neutrophil-mediated killing regulated?
It is regulated by cytokines such as GM-CSF, TNF-alpha, and IFN-gamma, and modulated by bacterial factors.
Why is neutrophil-mediated killing important for human health?
It is a first-line defense against bacterial infections and its impairment leads to severe infections.
Conclusion
GO:0070944 neutrophil-mediated killing of bacterium is a fundamental biological process that bridges innate immunity and bacterial pathogenesis. Understanding its molecular mechanisms and evasion strategies is essential for developing new therapies against antibiotic-resistant infections. CRISPR-based models and quantitative methods offer powerful approaches to dissect this process and identify therapeutic targets.
References
- 1. Long MB et al.. 2024. A Bispecific Monoclonal Antibody Targeting Psl and PcrV Enhances Neutrophil-Mediated Killing of Pseudomonas aeruginosa in Patients with Bronchiectasis.. Am J Respir Crit Care Med 210(1):35-46 PMID: 38754132
- 2. de Jong NWM et al.. 2019. Immune Evasion by Staphylococcus aureus.. Microbiol Spectr 7(2) PMID: 30927347
- 3. van Kessel KP et al.. 2014. Neutrophil-Mediated Phagocytosis of Staphylococcus aureus.. Front Immunol 5:467 PMID: 25309547
- 4. Castro JE et al.. 2025. Clinical isolates of Providencia rettgeri and Providencia Stuartii evades neutrophil-mediated killing by subverting neutrophil-extracellular traps.. Front Immunol 16:1636387 PMID: 41112272
- 5. Walker LL et al.. 2026. NeuO-mediated O-acetylation of uropathogenic Escherichia coli K1 capsule enhances resistance to phage and neutrophil killing.. J Bacteriol 208(3):e0061025 PMID: 41665341
- 6. Bhattacharya M et al.. 2020. Leukocidins and the Nuclease Nuc Prevent Neutrophil-Mediated Killing of Staphylococcus aureus Biofilms.. Infect Immun 88(10) PMID: 32719153
- 7. Nomani M et al.. 2021. Decreased neutrophil-mediated bacterial killing in COVID-19 patients.. Scand J Immunol 94(3):e13083 PMID: 35993347
- 8. Thorsted A et al.. 2023. Model-based assessment of neutrophil-mediated phagocytosis and digestion of bacteria across in vitro and in vivo studies.. CPT Pharmacometrics Syst Pharmacol 12(12):1972-1987 PMID: 37700716
